<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">mSphere</journal-id><journal-id journal-id-type="iso-abbrev">mSphere</journal-id><journal-id journal-id-type="hwp">msph</journal-id><journal-id journal-id-type="pmc">msph</journal-id><journal-id journal-id-type="publisher-id">mSphere</journal-id><journal-title-group><journal-title>mSphere</journal-title></journal-title-group><issn pub-type="epub">2379-5042</issn><publisher><publisher-name>American Society for Microbiology</publisher-name><publisher-loc>1752 N St., N.W., Washington, DC</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6763770</article-id><article-id pub-id-type="publisher-id">mSphere00554-19</article-id><article-id pub-id-type="doi">10.1128/mSphere.00554-19</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="overline"><subject>Molecular Biology and Physiology</subject></subj-group></article-categories><title-group><article-title>Characterization of the Self-Resistance Mechanism to Dityromycin in the <italic>Streptomyces</italic> Producer Strain</article-title><alt-title alt-title-type="running-head">Ribosomal Protein S12 Drives Dityromycin Resistance</alt-title><alt-title alt-title-type="short-authors">Fabbretti et al.</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Fabbretti</surname><given-names>Attilio</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>&#x000c7;apuni</surname><given-names>Retina</given-names></name><xref ref-type="aff" rid="aff2"><sup>b</sup></xref></contrib><contrib contrib-type="author"><name><surname>Giuliodori</surname><given-names>Anna Maria</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Cimarelli</surname><given-names>Lucia</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Miano</surname><given-names>Antonino</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Napolioni</surname><given-names>Valerio</given-names></name><xref ref-type="aff" rid="aff3"><sup>c</sup></xref></contrib><contrib contrib-type="author"><name><surname>La Teana</surname><given-names>Anna</given-names></name><xref ref-type="aff" rid="aff4"><sup>d</sup></xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Spurio</surname><given-names>Roberto</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><aff id="aff1"><label>a</label><addr-line>Laboratory of Genetics, School of Biosciences and Veterinary Medicine, University of Camerino, Camerino, Italy</addr-line></aff><aff id="aff2"><label>b</label><addr-line>Structural Biology Unit, CIC bioGUNE, Derio, Bizkaia, Spain</addr-line></aff><aff id="aff3"><label>c</label><addr-line>Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California, USA</addr-line></aff><aff id="aff4"><label>d</label><addr-line>Department of Life and Environmental Sciences, Polytechnic University of Marche, Ancona, Italy</addr-line></aff></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Fey</surname><given-names>Paul D.</given-names></name><role>Editor</role><aff>University of Nebraska Medical Center</aff></contrib></contrib-group><author-notes><corresp id="cor1">
Address correspondence to Roberto Spurio, <email>roberto.spurio@unicam.it</email>.</corresp><fn fn-type="other"><p><bold>Citation</bold> Fabbretti A, &#x000c7;apuni R, Giuliodori AM, Cimarelli L, Miano A, Napolioni V, La Teana A, Spurio R. 2019. Characterization of the self-resistance mechanism to dityromycin in the <italic>Streptomyces</italic> producer strain. mSphere 4:e00554-19. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/mSphere.00554-19">https://doi.org/10.1128/mSphere.00554-19</ext-link>.</p></fn></author-notes><pub-date pub-type="epub"><day>25</day><month>9</month><year>2019</year></pub-date><pub-date pub-type="collection"><season>Sep-Oct</season><year>2019</year></pub-date><volume>4</volume><issue>5</issue><elocation-id>e00554-19</elocation-id><history><date date-type="received"><day>31</day><month>7</month><year>2019</year></date><date date-type="accepted"><day>9</day><month>9</month><year>2019</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2019 Fabbretti et al.</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Fabbretti et al.</copyright-holder><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="mSphere.00554-19.pdf"/><abstract abstract-type="precis"><p>The World Health Organization has identified antimicrobial resistance as a substantial threat to human health. Because of the emergence of pathogenic bacteria resistant to multiple antibiotics worldwide, there is a need to identify the mode of action of antibiotics and to unravel the basic mechanisms responsible for drug resistance. Antibiotic producers&#x02019; microorganisms can protect themselves from the toxic effect of the drug using different strategies; one of the most common involves the modification of the antibiotic&#x02019;s target site. In this work, we report a detailed analysis of the molecular mechanism, based on protein modification, devised by the soil microorganism <italic>Streptomyces</italic> sp. strain AM-2504 to protect itself from the activity of the peptide antibiotic dityromycin. Furthermore, we demonstrate that this mechanism can be reproduced in <named-content content-type="genus-species">E. coli</named-content>, thereby eliciting antibiotic resistance in this human commensal bacterium.</p></abstract><abstract><title>ABSTRACT</title><p>Dityromycin is a peptide antibiotic isolated from the culture broth of the soil microorganism <italic>Streptomyces</italic> sp. strain AM-2504. Recent structural studies have shown that dityromycin targets the ribosomal protein S12 in the 30S ribosomal subunit, inhibiting translocation. Herein, by using <italic>in vitro</italic> protein synthesis assays, we identified the resistance mechanism of the producer strain to the secondary metabolite dityromycin. The results show that the self-resistance mechanism of the <italic>Streptomyces</italic> sp. strain AM-2504 is due to a specific modification of the ribosome. In particular, two amino acid substitutions, located in a highly conserved region of the S12 protein corresponding to the binding site of the antibiotic, were found. These mutations cause a substantial loss of affinity of the dityromycin for the 30S ribosomal subunit, protecting the producer strain from the toxic effect of the antibiotic. In addition to providing a detailed description of the first mechanism of self-resistance based on a mutated ribosomal protein, this work demonstrates that the molecular determinants of the dityromycin resistance identified in <italic>Streptomyces</italic> can be transferred to <named-content content-type="genus-species">Escherichia coli</named-content> ribosomes, where they can trigger the same antibiotic resistance mechanism found in the producer strain.</p><p><bold>IMPORTANCE</bold> The World Health Organization has identified antimicrobial resistance as a substantial threat to human health. Because of the emergence of pathogenic bacteria resistant to multiple antibiotics worldwide, there is a need to identify the mode of action of antibiotics and to unravel the basic mechanisms responsible for drug resistance. Antibiotic producers&#x02019; microorganisms can protect themselves from the toxic effect of the drug using different strategies; one of the most common involves the modification of the antibiotic&#x02019;s target site. In this work, we report a detailed analysis of the molecular mechanism, based on protein modification, devised by the soil microorganism <italic>Streptomyces</italic> sp. strain AM-2504 to protect itself from the activity of the peptide antibiotic dityromycin. Furthermore, we demonstrate that this mechanism can be reproduced in <named-content content-type="genus-species">E. coli</named-content>, thereby eliciting antibiotic resistance in this human commensal bacterium.</p></abstract><kwd-group><title>KEYWORDS</title><kwd>self-resistance</kwd><kwd>antibiotic</kwd><kwd>ribosomal protein S12</kwd><kwd>translation</kwd></kwd-group><funding-group><award-group id="award1"><funding-source><institution-wrap><institution>Ministero dell'Istruzione, dell'Universit&#x000e0; e della Ricerca (MIUR)</institution><institution-id>https://doi.org/10.13039/501100003407</institution-id></institution-wrap></funding-source><award-id>RBFR130VS5_001</award-id><principal-award-recipient><name><surname>Fabbretti</surname><given-names>Attilio</given-names></name></principal-award-recipient></award-group></funding-group><counts><count count="2" count-type="supplementary-material"/><fig-count count="4"/><table-count count="1"/><equation-count count="0"/><ref-count count="46"/><page-count count="10"/><word-count count="6399"/></counts><custom-meta-group><custom-meta><meta-name>cover-date</meta-name><meta-value>September/October 2019</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="s1"><title>INTRODUCTION</title><p>The emergence of multidrug-resistant (MDR) bacteria is a growing problem that represents one of the top three threats to global public health worldwide (<xref rid="B1" ref-type="bibr">1</xref><xref ref-type="bibr" rid="B2">&#x02013;</xref><xref rid="B4" ref-type="bibr">4</xref>). Moreover, it has been estimated that approximately 70% of infection-causing bacteria are already resistant to at least one antibiotic available in routine clinical practice. Therefore, all the efforts to provide a detailed molecular picture of a specific resistance mechanism can contribute positively to improve our understanding of antimicrobial resistance (AMR) and its dynamics.</p><p>Dityromycin is a cyclic decapeptide antibiotic (<xref ref-type="fig" rid="fig1">Fig.&#x000a0;1A</xref>) discovered as a secondary metabolite produced by <italic>Streptomyces</italic> sp. strain AM-2504 (<xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B6" ref-type="bibr">6</xref>). Its structure is almost identical to that of GE82832, a translocation inhibitor produced by <italic>Streptosporangium</italic> spp. (<xref rid="B7" ref-type="bibr">7</xref><xref ref-type="bibr" rid="B8">&#x02013;</xref><xref rid="B9" ref-type="bibr">9</xref>). Both molecules interact with the same ribosomal site and display the same mechanism of action, even if they are produced by different microorganisms. The interaction of dityromycin with the ribosome is peculiar compared to other ribosomal inhibitors, since it interacts exclusively with the ribosomal protein S12 without a direct interaction with the 16S rRNA (<xref ref-type="fig" rid="fig1">Fig.&#x000a0;1B</xref> and <xref ref-type="fig" rid="fig1">C</xref>) (<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B9" ref-type="bibr">9</xref>). Indeed, the binding of dityromycin to the ribosome is mediated by its interaction with five amino acids at the ribosomal protein S12, namely, arginine 30, valine 32, arginine 55, histidine 76, and valine 78 (<xref ref-type="fig" rid="fig1">Fig.&#x000a0;1C</xref>). Dityromycin inhibits protein synthesis by blocking the translocation of tRNA through the ribosome, while it has almost no effect on the accommodation of aminoacyl-tRNA into the P-site or the A-site, in the context of either the 30S ribosomal subunit or the 70S ribosome (<xref rid="B7" ref-type="bibr">7</xref>). Recent studies have shown that dityromycin blocks the EF-G-dependent translocation of peptidyl tRNA and mRNA without preventing the ribosomal binding of the elongation factor. In particular, dityromycin hampers the interaction between domain III of EF-G and protein S12, which is located near the decoding center of the ribosome, at the interface of two subunits (<xref rid="B9" ref-type="bibr">9</xref>, <xref rid="B10" ref-type="bibr">10</xref>).</p><fig id="fig1" orientation="portrait" position="float"><label>FIG&#x000a0;1</label><caption><p>Interaction of dityromycin with the 30S ribosomal subunit. (A) Chemical structure of the antibiotic dityromycin. (B) Three-dimensional (3D) structure of the 30S ribosomal subunit (gray) and localization of dityromycin (red) in contact with the ribosomal protein S12 (green). A, P, and E tRNA binding sites are indicated in blue, yellow, and violet, respectively. (C) Close-up of dityromycin (red) bound to S12 (green) missing the C-terminal domain. The amino acid residues of S12 involved in the interaction with the antibiotic are also indicated. (Modified from reference <xref rid="B9" ref-type="bibr">9</xref>.)</p></caption><graphic xlink:href="mSphere.00554-19-f0001"/></fig><p>A strict requirement to ensure that the antibiotic producer cell protects itself when the active metabolites are produced, accumulated, and released is to possess a self-resistance mechanism(s) (<xref rid="B11" ref-type="bibr">11</xref>). Microorganisms can adopt several strategies to develop self-resistance, such as (i) chemical modification of the target, as in the case of rRNA methylation or mutation (<xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B13" ref-type="bibr">13</xref>); (ii) activation of efflux pumps (<xref rid="B14" ref-type="bibr">14</xref>, <xref rid="B15" ref-type="bibr">15</xref>); (iii) sequestration of the natural product by proteins keeping the active compound in a bound and inactive state (<xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B17" ref-type="bibr">17</xref>); (iv) production of the antibiotic in a prodrug form, activated through selective cleavage by peptidases found in the periplasmic space, and subsequently released outside the cell (<xref rid="B18" ref-type="bibr">18</xref>, <xref rid="B19" ref-type="bibr">19</xref>); and (v) oxidative inactivation of the matured prodrug following export (<xref rid="B20" ref-type="bibr">20</xref>).</p><p>Biochemical and genetic similarities demonstrate that such resistance mechanisms have prefigured those found subsequently in antibiotic-resistant pathogens, which have acquired specific genes or gene clusters originally developed by antibiotic producers (<xref rid="B21" ref-type="bibr">21</xref>).</p><p>In this work, we have investigated the self-resistance mechanism developed by <italic>Streptomyces</italic> sp. strain AM-2504 toward the antibiotic activity of its natural product dityromycin. To prevent self-toxicity, this microorganism has evolved a strategy based on the production of a modified and self-resistant ribosomal protein variant. Our approach consisted in analyzing three aspects, namely, identification and biochemical characterization of the self-resistance mechanism, characterization of the amino acid residues of the ribosomal protein S12 involved in resistance by the heterologous expression of site-directed mutants in <named-content content-type="genus-species">Escherichia coli</named-content>, and a phylogenetic analysis of the dityromycin binding pocket in the ribosomal protein S12.</p></sec><sec sec-type="results" id="s2"><title>RESULTS</title><sec id="s2.1"><title>Identification of the mechanism conferring self-resistance.</title><p>To determine the self-resistance mechanism of <italic>Streptomyces</italic> sp. strain AM-2504 to dityromycin, we set up a simple experiment evaluating whether the resistance mechanism relied on possible modifications/secretion of the drug (prodrug or efflux pumps) or was based on mutations/methylations/modifications of the target.</p><p>A translational test programmed with poly(U) was used to compare cell extracts prepared from either <named-content content-type="genus-species">E. coli</named-content> (S30<sub>E.coli</sub>) or <italic>Streptomyces</italic> sp. strain AM-2504 cells (S30<sub>Str</sub>) in the presence or absence of the antibiotic. Dityromycin, an antibiotic targeting the translation elongation phase, completely inhibited protein synthesis with S30<sub>E.coli</sub> at concentrations ranging between 1 and 10&#x02009;&#x003bc;M, whereas it did not show any effect on the poly(U) translation carried out with S30<sub>Str</sub> (<xref ref-type="fig" rid="fig2">Fig.&#x000a0;2A</xref>). The lack of inhibition with the S30<sub>Str</sub> extract clearly excluded prodrug or efflux pumps as a possible self-resistance mechanism.</p><fig id="fig2" orientation="portrait" position="float"><label>FIG&#x000a0;2</label><caption><p>Identification of the self-resistance mechanism. (A and B) Effects of increasing concentration of dityromycin on poly(U) <italic>in vitro</italic> translation based on S30 cell extract of <named-content content-type="genus-species">E. coli</named-content> (red) or <italic>Streptomyces</italic> sp. strain AM-2504 (black) (A) or crisscrossed assays using post-ribosomal supernatant (S100) and 70S ribosomes of <italic>Streptomyces</italic> sp. strain AM-2504 or of <named-content content-type="genus-species">E. coli</named-content> (B). <italic>Streptomyces</italic> 70S incubated with <named-content content-type="genus-species">E. coli</named-content> S100 or <italic>Streptomyces</italic> S100 is indicated in blue or black, respectively. <named-content content-type="genus-species">E. coli</named-content> 70S incubated with either <named-content content-type="genus-species">E. coli</named-content> S100 or <italic>Streptomyces</italic> S100 is indicated in red or green, respectively. (C) Residual translation inhibition activity of the supernatants obtained from ultracentrifugation of 30S ribosomes preincubated with dityromycin. After centrifugation of increasing amounts of <named-content content-type="genus-species">E. coli</named-content> 30S (black) and <italic>Streptomyces</italic> sp. strain AM-2504 30S (red), the residual inhibition activity of the supernatants was determined in a poly(U) translation test (further details are provided in Materials and Methods).</p></caption><graphic xlink:href="mSphere.00554-19-f0002"/></fig><p>To test whether this self-resistance mechanism was caused by protective mutations in the ribosomes or by an enzymatic activity able to modify/deactivate the antibiotic, 70S ribosomes were separated by ultracentrifugation from the post-ribosomal supernatant (S100) and the fractions were tested by crossed <italic>in vitro</italic> poly(U) translation assays. In particular, the effect of dityromycin on <italic>Streptomyces</italic> 70<italic>S</italic> ribosomes (70S<sub>Str</sub>) was assayed in the presence of <named-content content-type="genus-species">E. coli</named-content> S100 (S100<sub>E.coli</sub>). <italic>Vice versa</italic>, <italic>Streptomyces</italic> S100 extract (S100<sub>Str</sub>) was tested with <named-content content-type="genus-species">E. coli</named-content> 70S ribosomes (70S<sub>E.coli</sub>). The results of this experiment (<xref ref-type="fig" rid="fig2">Fig.&#x000a0;2B</xref>) show that the reaction mixtures consisting of S100<sub>Str</sub> plus 70S<sub>E.coli</sub> and S100<sub>E.coli</sub> plus 70S<sub>E.coli</sub> were totally inhibited by dityromycin, whereas those formed by S100<sub>E.coli</sub> plus 70S<sub>Str</sub> and S100<sub>Str</sub> plus 70S<sub>Str</sub> were not. These results strongly indicate that the modifications causing the self-resistance of the producer strain lie on the ribosome.</p><p>Since the target of dityromycin is the ribosomal protein S12 (<xref rid="B9" ref-type="bibr">9</xref>), 30S ribosomal subunits from both <named-content content-type="genus-species">E. coli</named-content> and <italic>Streptomyces</italic> sp. strain AM-2504 were purified. Increasing concentrations of these isolated particles were used in a pulldown assay conducted in the presence of a fixed concentration of the antibiotic. After ultracentrifugation at 300,000&#x02009;&#x000d7;&#x02009;<italic>g</italic>, the supernatants were tested in a translational system based on <named-content content-type="genus-species">E. coli</named-content> cell extracts programmed with poly(U) to detect the residual presence of unbound dityromycin (see Materials and Methods). As reported in <xref ref-type="fig" rid="fig2">Fig.&#x000a0;2C</xref>, the supernatant resulting from the pulldown of <named-content content-type="genus-species">E. coli</named-content> 30S subunits incubated with dityromycin did not interfere with poly(Phe) synthesis. Conversely, the supernatant obtained after centrifugation of <italic>Streptomyces</italic> 30S subunits incubated with dityromycin inhibited the reaction. This result indicates that dityromycin is not bound by the <italic>Streptomyces</italic> 30S subunits and is not pulled down during ultracentrifugation, even at high concentrations of ribosomes. In contrast, dityromycin stably interacts with the <named-content content-type="genus-species">E. coli</named-content> 30S subunits and is thus removed from the supernatant during the centrifugation step (<xref ref-type="fig" rid="fig2">Fig.&#x000a0;2C</xref>). In conclusion, the present results point to a self-resistance mechanism based on a mutation/modification residing in the small ribosomal subunit.</p></sec><sec id="s2.2"><title>Sequencing of the S12 gene reveals three amino acid substitutions in the dityromycin binding site.</title><p>As shown in the crystallographic structure of <xref ref-type="fig" rid="fig1">Fig.&#x000a0;1</xref>, dityromycin binds the 30S subunit by interacting exclusively with five critical positions of the ribosomal protein S12, namely, Arg30, Val32, Arg55, His76, and Val78 (<xref ref-type="fig" rid="fig1">Fig.&#x000a0;1C</xref>). To clarify the role played by S12 in reducing the binding affinity of dityromycin to the 30S<sub>Str</sub> subunit (<xref ref-type="fig" rid="fig2">Fig.&#x000a0;2</xref>), we sequenced the <italic>rpsL</italic> gene, encoding the S12 protein of <italic>Streptomyces</italic> sp. strain AM-2504. In addition, we sequenced the entire genome of the producer strain, thus obtaining its first annotated draft genome sequence (<xref rid="B22" ref-type="bibr">22</xref>). The comparison of <italic>Streptomyces</italic> sp. strain AM-2504 genome with the sequences available in the NCBI genome data bank allowed us to verify that the strain named AM-2504 described in this study exhibits 98.6% nucleotide identity with <named-content content-type="genus-species">Streptomyces kasugaensis</named-content>. Therefore, it is conceivable that <italic>Streptomyces</italic> sp. strain AM-2504 can be classified as <named-content content-type="genus-species">S. kasugaensis</named-content>.</p><p>DNA sequence data demonstrate that three out of five amino acids located in the dityromycin binding site of S12, namely, Val32Thr, Arg55Lys, and Val78Ile, are different from those found in the model organism <named-content content-type="genus-species">E. coli</named-content> (<xref ref-type="fig" rid="fig3">Fig.&#x000a0;3</xref>). These substitutions are likely the molecular determinants of the self-resistance mechanism to the antibiotic, preventing dityromycin binding to the ribosome (<xref ref-type="fig" rid="fig2">Fig.&#x000a0;2C</xref>).</p><fig id="fig3" orientation="portrait" position="float"><label>FIG&#x000a0;3</label><caption><p>Sequence of the <italic>rpsL</italic> gene of <italic>Streptomyces</italic> sp. strain AM-2504. Nucleotide and amino acid sequences of ribosomal protein S12 <italic>of Streptomyces</italic> sp. strain AM-2504. The amino acids involved in the interaction with the antibiotic in dityromycin-sensitive ribosomes are circled. Amino acids involved in the self-resistance mechanism are circled in red.</p></caption><graphic xlink:href="mSphere.00554-19-f0003"/></fig></sec><sec id="s2.3"><title>Expression of the S12 mutant proteins in <named-content content-type="genus-species">E. coli</named-content> confers resistance to dityromycin.</title><p>To verify whether these mutations are responsible for the self-resistance of the producer strain, single substitutions at Val32, Arg55, and Val78 were introduced into the <named-content content-type="genus-species">E. coli</named-content>
<italic>rpsL</italic> gene, and the mutant genes were provided in <italic>trans</italic> to the <named-content content-type="genus-species">E. coli</named-content> BL21 strain grown in the presence of increasing concentrations of dityromycin. The experimental system was based on gene expression from the high-copy-number plasmid pET11a, which contained the <italic>rpsL</italic> gene isolated from <named-content content-type="genus-species">E. coli</named-content> MC4100 carrying the original mutation Lys42Arg, which confers resistance to the antibiotic streptomycin. As shown in <xref ref-type="fig" rid="fig4">Fig.&#x000a0;4A</xref>, <named-content content-type="genus-species">E. coli</named-content> cells expressing a wild-type copy of S12, in the absence of the plasmid, are sensitive to streptomycin, but they become resistant once transformed. Moreover, the presence of either Val32Thr, Arg55Lys or Val78Ile substitutions did not affect the streptomycin-resistant phenotype. This demonstrates that the ribosomes effectively incorporate the S12 protein encoded by the plasmid and respond to the mutant genetic background supplied in <italic>trans</italic>. Furthermore, the results shown in <xref ref-type="fig" rid="fig4">Fig.&#x000a0;4B</xref> demonstrate that the ribosomal protein S12 carrying the Val32Thr or Arg55Lys substitution confer dityromycin resistance to <named-content content-type="genus-species">E. coli</named-content>, whereas the cells expressing the point mutation Val78Ile proved to be susceptible to this antibiotic.</p><fig id="fig4" orientation="portrait" position="float"><label>FIG&#x000a0;4</label><caption><p>Mutations in ribosomal protein S12 confer resistance to dityromycin in <named-content content-type="genus-species">E. coli</named-content>. (A) Determination of MIC of streptomycin on <named-content content-type="genus-species">E. coli</named-content> BL21(DE3)/pLysS (a) transformed with pET11a-rpsl<sub>K42R</sub> (b) or with pET11a-rpsl<sub>K42R</sub> carrying the site-directed mutation of the dityromycin binding pocket V32T (c), R55K (d), or V78I (e). (B) Determination of MIC of dityromycin on <named-content content-type="genus-species">E. coli</named-content> BL21(DE3)<italic>/</italic>pLysS transformed with pET11a-rpsl<sub>K42R</sub> (a) or with pET11a-rpsl<sub>K42R</sub> carrying the site-directed mutation of the dityromycin binding pocket V32T (b), R55K (c), or V78I (d). The streptomycin concentrations were 0, 0.5, 1.0, 2.0, 4.0, 8.0, 16.0, 32.0, 64.0, 128.0, 256.0, and 512.0&#x02009;&#x003bc;g/ml in lanes 1 to 12, respectively. The dityromycin concentrations were 0, 0.39, 0.78, 1.56, 3.12, 6.25, 12.5, 25.0, 50.0, 100.0, 200.0, and 400.0&#x02009;&#x003bc;g/ml from lanes 1 to 12, respectively.</p></caption><graphic xlink:href="mSphere.00554-19-f0004"/></fig></sec></sec><sec sec-type="discussion" id="s3"><title>DISCUSSION</title><p>The growing number of bacterial pathogens uniquely adapted to survive in the presence of one or more antibiotics is an extremely serious threat to global health. The term &#x0201c;antibiotic resistome,&#x0201d; a large repertoire of genes that has been originally developed by bacteria and is currently remodeled by the selective pressure imposed by drug use/abuse, has been coined to describe the genetic determinants involved in antibiotic resistance (<xref rid="B23" ref-type="bibr">23</xref>, <xref rid="B24" ref-type="bibr">24</xref>).</p><p>Resistance to antibiotics is tightly linked to their production, since microorganisms producing these molecules must protect themselves against their action. In many cases, mechanisms of self-resistance have been shown to be mechanistically similar to the ones identified in clinical pathogens (<xref rid="B25" ref-type="bibr">25</xref>). Resistance genes are often carried by the same gene cluster of the antibiotic biosynthetic enzymes, and their expression is temporally coupled. Indeed, antibiotic producer cells need to express resistance determinants prior to, or concomitantly with, synthesis of the antibiotic molecule (<xref rid="B26" ref-type="bibr">26</xref>, <xref rid="B27" ref-type="bibr">27</xref>). In recent years, the analysis of several genomes suggested that microorganisms produce only a fraction of the secondary metabolites that they encode, and new approaches have been used to identify biosynthetic gene clusters whose expression can be induced. The colocalization of resistance genes and biosynthetic genes in the genomes of underexploited groups of secondary metabolite producers, for example, has been used in pursuit of new biosynthetic pathways. This genome mining approach, guided by the search for self-resistant determinants, has been successful for topoisomerase inhibitors whose biosynthetic gene cluster has been identified by looking for putative pentapeptide repeat proteins, which are known to confer self-resistance to these molecules (<xref rid="B28" ref-type="bibr">28</xref>).</p><p>More than half of the antibiotics currently used inhibit protein synthesis by binding to the functional centers of the ribosome. Recently, important insights into the mechanism of these antibiotics have been obtained by X-ray crystallography and cryo-electron microscopy (Cryo-EM) analysis, opening the possibility of developing new molecules by structure-based drug design (<xref rid="B29" ref-type="bibr">29</xref><xref ref-type="bibr" rid="B30">&#x02013;</xref><xref rid="B36" ref-type="bibr">36</xref>).</p><p>In this work, we characterized the mechanism of self-resistance of the dityromycin producer <italic>Streptomyces</italic> sp. strain AM-2504. Using <named-content content-type="genus-species">E. coli</named-content> and <italic>Streptomyces</italic>-based <italic>in vitro</italic> translation assays in combination with an ultracentrifugation pulldown assay, we demonstrated that the resistance determinants are localized in the <italic>Streptomyces</italic> 30S ribosomal subunit. Since the target of dityromycin is the ribosomal protein S12, we sequenced the gene coding for <italic>Streptomyces</italic> S12 and compared it with its <named-content content-type="genus-species">E. coli</named-content> homolog. Three amino acids in the <italic>Streptomyces</italic> protein (out of the five involved in the interaction with the antibiotic) differed from the <named-content content-type="genus-species">E. coli</named-content> protein sequence. Therefore, we suggest that the molecular basis underlying the self-resistance mechanism could be the reduced affinity of the antibiotic toward its target due to the amino acid substitutions on the ribosomal protein S12. To confirm this hypothesis, we introduced the observed amino acid substitutions into a plasmid-borne copy of <named-content content-type="genus-species">E. coli</named-content>
<italic>rpsL</italic> gene harboring another mutation conferring resistance to the antibiotic streptomycin. The observed streptomycin resistance phenotype provides explicit, albeit indirect, evidence that the plasmid gene encoding ribosomal protein S12 is effectively incorporated into the 30S subunits. Even though the setup of the assay did not allow strict quantification of the number of copies of mutant protein incorporated, it showed unequivocally that this incorporation took place and that plasmid-encoded S12 bearing two specific mutations in the dityromycin binding site conferred resistance to the antibiotic. The results shown in <xref ref-type="fig" rid="fig4">Fig.&#x000a0;4B</xref> clearly indicate the effects of amino acid replacements at the three key sites of ribosomal protein S12 involved in the binding of the antibiotic. In particular, at position 32, the substitution of the nonpolar aliphatic valine with the polar amino acid threonine interferes with the hydrophobic interaction established with the dityrosine group of dityromycin according to the crystal structure of the dityromycin-30S complex. It has been pointed out by crystallographic analysis that the arginine at position 55 packs against the <italic>N</italic>,<italic>N</italic>-dimethyl valine of the antibiotic (<xref rid="B9" ref-type="bibr">9</xref>). Our results strongly indicate that the replacement of a positively charged side chain, as in the case of lysine, is not sufficient to maintain the correct structure of the binding site, which presumably requires the chemical properties of the guanidinium group of arginine. This finding is consistent with the high specificity demonstrated by the arginine side chain in the interaction of proteins with their substrates (<xref rid="B37" ref-type="bibr">37</xref>, <xref rid="B38" ref-type="bibr">38</xref>). On the other hand, we demonstrate that the substitution of Val78 with isoleucine does not interfere with the interaction of dityromycin with S12.</p><p>To identify the degree of conservation of the amino acid residues responsible for dityromycin resistance, we aligned the S12 sequences to 72 <italic>Streptomyces</italic> spp. randomly selected from the NCBI database. The alignment shows that, of the three residues considered, only Ile78 (Val in <named-content content-type="genus-species">E. coli</named-content>) is conserved in all <italic>Streptomyces</italic> sequences analyzed. The other two key residues are quite rare, with Thr32 (Val in <named-content content-type="genus-species">E. coli</named-content>) reported only in 7 out of 72 genomes (<italic>Streptomyces antioxidans</italic>, <italic>S. autoliticus</italic>, <italic>S. gilvosporeus</italic>, <italic>S. iranensis</italic>, <italic>S. malaysiensis</italic>, <italic>S. natalensis</italic>, and <italic>S. violaceusniger</italic>) and Lys55 (Arg in <named-content content-type="genus-species">E. coli</named-content>) in only two strains, <italic>S. gilvosporeus</italic> and <italic>S. natalensis</italic>. Therefore, the results of this comparative analysis show that only 2 of 72 <italic>Streptomyces</italic> strains share the same S12 residues conferring resistance to dityromycin as <italic>Streptomyces</italic> sp. strain AM-2504 (see <xref ref-type="supplementary-material" rid="figS1">Fig.&#x000a0;S1</xref> in the supplemental material). When the comparative analysis was extended to 30 bacterial strains randomly covering all relevant branches of the phylogenetic tree, it was found that all selected bacteria display a valine at position 32, embedded in a stretch of four amino acids (RGVC), which is highly conserved and it is part of the &#x0201c;core&#x0201d; of a pseudo beta-barrel of S12 (<xref ref-type="supplementary-material" rid="figS2">Fig.&#x000a0;S2A</xref> and <xref ref-type="supplementary-material" rid="figS2">S2B</xref>). The other two residues are less conserved, since Lys55 and Ile78 are found in 4 strains and 11 bacterial strains, respectively.</p><supplementary-material content-type="local-data" id="figS1"><object-id pub-id-type="doi">10.1128/mSphere.00554-19.1</object-id><label>FIG&#x000a0;S1</label><p>Alignment of the amino acid sequence of ribosomal protein S12 from 72 <italic>Streptomyces</italic> strains. The arrows indicate the amino acids that are involved in dityromycin binding that are different from those in the <named-content content-type="genus-species">E. coli</named-content> counterpart. Download <inline-supplementary-material id="fS1" mimetype="image" mime-subtype="jpg" xlink:href="mSphere.00554-19-sf001.jpg" content-type="local-data">FIG&#x000a0;S1, JPG file, 2.2 MB</inline-supplementary-material>.</p><permissions><copyright-statement>Copyright &#x000a9; 2019 Fabbretti et al.</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Fabbretti et al.</copyright-holder><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/"><license-p>This content is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p></license></permissions></supplementary-material><supplementary-material content-type="local-data" id="figS2"><object-id pub-id-type="doi">10.1128/mSphere.00554-19.2</object-id><label>FIG&#x000a0;S2</label><p>(A) Alignment of the amino acid sequence of ribosomal protein S12 from 30 bacterial species. The arrows indicate the amino acids involved in dityromycin binding, and the red box indicates the highly conserved RGVC sequence motif. (B) Phylogenetic tree representing the relatedness of ribosomal protein S12 of the bacterial species reported in panel A. Download <inline-supplementary-material id="fS2" mimetype="image" mime-subtype="tif" xlink:href="mSphere.00554-19-sf002.tif" content-type="local-data">FIG&#x000a0;S2, TIF file, 2.6 MB</inline-supplementary-material>.</p><permissions><copyright-statement>Copyright &#x000a9; 2019 Fabbretti et al.</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Fabbretti et al.</copyright-holder><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/"><license-p>This content is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p></license></permissions></supplementary-material><p>To our knowledge, the results of this work represent the first example of a self-resistance mechanism mediated by a ribosomal protein in the producer strain. Resistance mechanisms identified by isolation of single mutations are extremely rare among ribosomal proteins. Point mutations in <italic>rpsL</italic>, the gene encoding S12, have been identified as the key factor conferring streptomycin resistance (<xref rid="B39" ref-type="bibr">39</xref>) and at the same time activate the expression of cryptic antibiotics, like the blue-colored actinorodhin (<xref rid="B40" ref-type="bibr">40</xref>, <xref rid="B41" ref-type="bibr">41</xref>). This intriguing finding, which is the first reported evidence of an effect induced on gene expression by a point mutation located on a ribosomal protein, is still lacking a detailed explanation at the molecular level. A few other examples include protein L3, where a single mutation has been shown to confer resistance to tiamulin, the semisynthetic derivative of pleuromutiline, reducing its binding affinity for the ribosome and mutations in L16 conferring resistance to the oligosaccharide antimicrobial agents avilamycin (<xref rid="B42" ref-type="bibr">42</xref>) and evernimicin (<xref rid="B43" ref-type="bibr">43</xref>). In <named-content content-type="genus-species">Pasteurella multocida</named-content>, a bacterium responsible for zoonotic diseases, a combination of amino acid changes on ribosomal protein S5 (point mutation at Ser32 and amino acid deletion at Phe33) and a single transversion in helix 34 of 16S rRNA have been identified as the molecular determinants of spectinomycin resistance (<xref rid="B44" ref-type="bibr">44</xref>).</p><p>In summary, we can conclude that <italic>Streptomyces</italic> sp. strain AM-2504 has developed a successful strategy to protect its own ribosomes from the effect of dityromycin, combining the effects of three amino acid substitutions, which occur as isolated point mutations in other Actinomyces strains and are compatible with the structural function of ribosomal protein S12. Although this resistance mechanism does not fall into the category of antibiotic resistance transfer and spreading, in a strict sense, the characterization of this strategy at the molecular level adds a new piece to the complex puzzle underlying the coevolution of antibiotic production and self-resistance mechanisms.</p></sec><sec sec-type="materials|methods" id="s4"><title>MATERIALS AND METHODS</title><sec id="s4.1"><title>Media.</title><p>ISP2 medium (sporulation agar) consists of 0.4% yeast extract, 0.4% glucose, 1% malt extract, and 2% agar. T1 medium contains 1% glucose, 2% starch, 0.5% yeast extract, 0.5% peptone, and 0.4% CaCO<sub>3</sub>. JM medium consists of 0.1% yeast extract, 0.1% MgCl<sub>2</sub> (6H<sub>2</sub>O), 0.3% Tryptone Soya, and 10% sucrose. In all cases, the pH of the medium was adjusted to 7.0 prior to autoclaving. Luria-Bertani medium was used for the growth of <named-content content-type="genus-species">Escherichia coli</named-content> strains utilized for propagation of plasmids and for the preparation of ribosomes and cell extracts.</p></sec><sec id="s4.2"><title>Culture conditions of <italic>Streptomyces</italic> sp. strain AM-2504.</title><p>For the production and isolation of spores, <italic>Streptomyces</italic> sp. strain AM-2504 was grown in ISP2 medium for 7 to 10&#x02009;days at 28&#x000b0;C. The white aerial mycelium, consisting of spores, was stripped from the upper layer of the plate using a spatula and dispersed into 1&#x02009;ml of sterile water. The spore suspension was filtered through a wad of absorbent cotton, and the spores were concentrated by centrifugation at 4,000&#x02009;rpm for 15&#x02009;min. The spores were resuspended in 100&#x02009;&#x003bc;l of 20% glycerol and stored at &#x02013;20&#x000b0;C.</p></sec><sec id="s4.3"><title>Genomic DNA extraction.</title><p><italic>Streptomyces</italic> spores (20&#x02009;&#x003bc;l) were inoculated in 20&#x02009;ml of JM medium at 28&#x000b0;C for 18 h with aeration. Cells were collected by centrifugation, and genomic DNA was extracted using the Invisorb spin plant minikit (Invitek).</p></sec><sec id="s4.4"><title>DNA amplification and sequence of <italic>rpsL</italic> from <italic>Streptomyces</italic> sp.</title><p>Oligonucleotide primers GSF1 and GSR1 (<xref rid="tab1" ref-type="table">Table&#x000a0;1</xref>), designed to cover the coding region of the <italic>rpsL</italic> gene from <italic>Streptomyces</italic>, were used to amplify by PCR the target gene using genomic DNA as the template. The DNA sequence of the amplicon, covering approximately 95% of the coding region, was analyzed to identify the amino acid variants carried by the antibiotic producer strain.</p><table-wrap id="tab1" orientation="portrait" position="float"><label>TABLE&#x000a0;1</label><caption><p>Oligonucleotide primers used in this study</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col span="1"/><col span="1"/><col span="1"/></colgroup><thead><tr><th rowspan="1" colspan="1">Primer</th><th rowspan="1" colspan="1">DNA sequence (5&#x02032;&#x02192;3&#x02032;)<xref ref-type="table-fn" rid="ngtab1.1"><sup><italic>a</italic></sup></xref></th><th rowspan="1" colspan="1">Target</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Forward mutagenic primer</td><td rowspan="1" colspan="1">CCGCAAAAACGTGGC<underline>ACA</underline>TGTACTCGTG</td><td rowspan="1" colspan="1">Amino acid substitution Val32&#x02192;Thr32</td></tr><tr><td rowspan="1" colspan="1">Reverse mutagenic primer</td><td rowspan="1" colspan="1">CACGAGTACA<underline>TGT</underline>GCCACGTTTTTGCGG</td><td rowspan="1" colspan="1">Amino acid substitution Val32&#x02192;Thr32</td></tr><tr><td rowspan="1" colspan="1">Forward mutagenic primer</td><td rowspan="1" colspan="1">GTATGCCGTGTT<underline>AAA</underline>CTGACTAACGGTTTCG</td><td rowspan="1" colspan="1">Amino acid substitution Arg55&#x02192;Lys55</td></tr><tr><td rowspan="1" colspan="1">Reverse mutagenic primer</td><td rowspan="1" colspan="1">CGAAACCGTTAGTCAG<underline>TTT</underline>AACACGGCATAC</td><td rowspan="1" colspan="1">Amino acid substitution Arg55&#x02192;Lys55</td></tr><tr><td rowspan="1" colspan="1">Forward mutagenic primer</td><td rowspan="1" colspan="1">CAGGAGCACTCC<underline>ATA</underline>ATCCTGATCCGTG</td><td rowspan="1" colspan="1">Amino acid substitution Val78&#x02192;Ile78</td></tr><tr><td rowspan="1" colspan="1">Reverse mutagenic primer</td><td rowspan="1" colspan="1">CACGGATCAGGAT<underline>TAT</underline>GGAGTGCTCCTG</td><td rowspan="1" colspan="1">Amino acid substitution Val78&#x02192;Ile78</td></tr><tr><td rowspan="1" colspan="1"><italic>rpsL</italic>-specific forward primer (GSF1)</td><td rowspan="1" colspan="1">GTGCCTACGATCCAGCAGCTG</td><td rowspan="1" colspan="1"><italic>Streptomyces rpsL</italic> gene</td></tr><tr><td rowspan="1" colspan="1"><italic>rpsL</italic>-specific reverse primer (GSR1)</td><td rowspan="1" colspan="1">TTACTTCTCCTTCTTGGCGCCG</td><td rowspan="1" colspan="1"><italic>Streptomyces rpsL</italic> gene</td></tr></tbody></table><table-wrap-foot><fn fn-type="other" id="ngtab1.1"><label>a</label><p>The underlined nucleotides are the mutant triplet introduced by site-directed mutagenesis.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s4.5"><title>Site-directed mutagenesis.</title><p>Mutations in the <named-content content-type="genus-species">E. coli</named-content>
<italic>rpsL</italic> gene were obtained using the QuikChange XL kit (Stratagene) and, as the template for the PCR, the plasmid vector pET11a carrying the coding sequence of S12, derived from <named-content content-type="genus-species">E. coli</named-content> MC4100 (<italic>rpsL150</italic> [Str<sup>r</sup>]). The DNA sequences of the oligonucleotide primers used to introduce codon variants are indicated in <xref rid="tab1" ref-type="table">Table&#x000a0;1</xref>. <named-content content-type="genus-species">E. coli</named-content> DH5 cells were transformed with the mutagenized plasmids, and Sanger DNA sequencing confirmed the presence of mutated nucleotides.</p></sec><sec id="s4.6"><title>Preparation of <named-content content-type="genus-species">E. coli</named-content> and <italic>Streptomyces</italic> S30 cell extracts.</title><p><named-content content-type="genus-species">E. coli</named-content> MRE600 cells were grown at 37&#x000b0;C in LB medium until they reached mid-log phase, while <italic>Streptomyces</italic> cells were grown at 28&#x000b0;C in T1 medium for 45&#x02009;h. Both cell types were disrupted by grinding with precooled alumina in a chilled mortar and processed following a previously described protocol (<xref rid="B45" ref-type="bibr">45</xref>). Both S30 extracts were extensively dialyzed against a buffer containing 10&#x02009;mM Tris-HCl (pH 7.7), 10&#x02009;mM Mg acetate, 60&#x02009;mM NH<sub>4</sub>Cl, and 0.5&#x02009;mM dithiothreitol (DTT) and stored in small aliquots at &#x02013;80&#x000b0;C.</p></sec><sec id="s4.7"><title>Isolation of ribosomes and ribosomal subunits.</title><p>The crude extract S30 was subjected to ultracentrifugation at 100,000&#x02009;&#x000d7;&#x02009;<italic>g</italic> for 17 h at 4&#x000b0;C. The supernatant, called S100, was stored at &#x02013;80&#x000b0;C, while the pellet, consisting of 70S ribosomes, was resuspended and split in two aliquots, one for <italic>in vitro</italic> assays and one for preparation of 30S and 50S ribosomal subunits. 70S ribosomes were dissociated into subunits at 1&#x02009;mM Mg<sup>2+</sup> concentration by ultracentrifugation at 25,000&#x02009;rpm for 17h at 4&#x000b0;C in a swing bucket rotor (SW28), on a 10% to 30% sucrose density gradient (<xref rid="B45" ref-type="bibr">45</xref>).</p></sec><sec id="s4.8"><title><italic>In vitro</italic> translation assays.</title><p>Cell-free systems programmed with either poly(U) or 027 model mRNA were used to investigate the effect of dityromycin on the bacterial translational apparatus. Translation activity tests were performed using either S30 extracts or S100 extracts and 70S ribosomes, or crisscrossed combinations of <named-content content-type="genus-species">E. coli</named-content> and <italic>Streptomyces</italic> sp. S100 extracts and 70S ribosomes (<xref rid="B46" ref-type="bibr">46</xref>).</p></sec><sec id="s4.9"><title>Ribosome pulldown assay.</title><p>The binding of dityromycin to either <italic>Streptomyces</italic> or <named-content content-type="genus-species">E. coli</named-content> 30S ribosomal subunits was monitored by an ultracentrifugation-based assay. Increasing concentrations of 30S subunits were incubated for 10 min at room temperature with a fixed amount of antibiotic (1&#x02009;&#x003bc;M) in 90&#x02009;&#x003bc;l of a solution consisting of 10&#x02009;mM Tris-HCl (pH 7.7), 10&#x02009;mM Mg acetate, 60&#x02009;mM NH<sub>4</sub>Cl, and 0.5&#x02009;mM DTT. After ultracentrifugation in a S-100 AT-3 rotor at 100,000&#x02009;rpm for 1&#x02009;h at 4&#x000b0;C, aliquots of 20&#x02009;&#x003bc;l of the supernatant were removed and tested in poly(U)-dependent <italic>in vitro</italic> translation assays.</p></sec><sec id="s4.10"><title>Determination of MIC.</title><p>To verify the incorporation of S12 mutants in <named-content content-type="genus-species">E. coli</named-content> ribosomes, a MIC plate (5 rows &#x000d7; 12 wells) was set up with increasing concentrations of streptomycin, ranging from 0.0&#x02009;&#x003bc;g/&#x003bc;l to 512.0&#x02009;&#x003bc;g/&#x003bc;l. Each well of the plate contained 190&#x02009;&#x003bc;l of <named-content content-type="genus-species">E. coli</named-content> BL21(DE3)/pLysS cell culture. The plate rows contained the following: (i) no-plasmid control, (ii) pET11a expression vector with <italic>rpsL150</italic>, (iii) mutant V32/T32, (iv) mutant R55/K55, and (v) mutant V78/I78.</p><p>A MIC plate (4 rows &#x000d7; 12 wells) with the four tester strains and a gradient of dityromycin (from 0.0&#x02009;&#x003bc;g/&#x003bc;l to 400&#x02009;&#x003bc;g/&#x003bc;l) was used to estimate the ability of the mutant proteins to counteract the presence of the antibiotic. Further details are provided in the legend to <xref ref-type="fig" rid="fig4">Fig.&#x000a0;4</xref>.</p></sec></sec></body><back><ack><title>ACKNOWLEDGMENTS</title><p>We especially thank Satoshi &#x0014c;mura for providing the dityromycin producer strain <italic>Streptomyces</italic> sp. AM-2504 and Claudio Gualerzi for fruitful discussions. We also thank Georgia Lattanzi for helping during her laboratory training.</p><p>This work was supported by FIRB Futuro in Ricerca from the Ministero Italiano dell&#x02019;Istruzione, dell&#x02019;Universit&#x000e0; e della Ricerca (RBFR130VS5 001) to Attilio Fabbretti and by Progetto Strategico di Ateneo 2017 from Polytechnic University of Marche (Italy) to Anna La Teana.
</p></ack><ref-list><title>REFERENCES</title><ref id="B1"><label>1.</label><mixed-citation publication-type="book"><collab>World Health Organization</collab>. <year>2000</year>
<source>Overcoming antibiotic resistance. World Health Organization Report on Infectious Diseases 2000</source>. <publisher-name>World Health Organization</publisher-name>, <publisher-loc>Geneva, Switzerland</publisher-loc>.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Singer</surname><given-names>RS</given-names></name>, <name name-style="western"><surname>Finch</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Wegener</surname><given-names>HC</given-names></name>, <name name-style="western"><surname>Bywater</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Walters</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Lipsitch</surname><given-names>M</given-names></name></person-group>
<year>2003</year>
<article-title>Antibiotic resistance &#x02013; the interplay between antibiotic use in animals and human beings</article-title>. <source>Lancet Infect Dis</source>
<volume>3</volume>:<fpage>47</fpage>&#x02013;<lpage>51</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S1473-3099(03)00490-0</pub-id>.<pub-id pub-id-type="pmid">12505035</pub-id></mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation publication-type="book"><collab>Review on Antimicrobial Resistance</collab>. <year>2016</year>
<source>Tackling drug-resistant infections globally: final report and recommendations</source>. <publisher-name>The Review on Antimicrobial Resistance</publisher-name>, <publisher-loc>London, United Kingdom</publisher-loc>.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Friedrich</surname><given-names>AW</given-names></name></person-group>
<year>2019</year>
<article-title>Control of hospital acquired infections and antimicrobial resistance in Europe: the way to go</article-title>. <source>Wien Med Wochenschr</source>
<volume>169</volume>:<fpage>25</fpage>&#x02013;<lpage>30</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s10354-018-0676-5</pub-id>.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Omura</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Iwai</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Hirano</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Awaya</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Suzuki</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Matsumoto</surname><given-names>K</given-names></name></person-group>
<year>1977</year>
<article-title>A new antibiotic, AM-2504</article-title>. <source>Agric Biol Chem</source>
<volume>41</volume>:<fpage>1827</fpage>&#x02013;<lpage>1828</lpage>. doi:<pub-id pub-id-type="doi">10.1271/bbb1961.41.1827</pub-id>.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thesima</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Nishikawa</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kubota</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Shiba</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Iwai</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Omura</surname><given-names>S</given-names></name></person-group>
<year>1988</year>
<article-title>The structure of an antibiotic, dityromycin</article-title>. <source>Tetrahedon Lett</source>
<volume>29</volume>:<fpage>1963</fpage>&#x02013;<lpage>1966</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0040-4039(00)82090-0</pub-id>.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brandi</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Fabbretti</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Di Stefano</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Lazzarini</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Abbondi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Gualerzi</surname><given-names>CO</given-names></name></person-group>
<year>2006</year>
<article-title>Characterization of GE82832, a peptide inhibitor of translocation interacting with bacterial 30S subunit</article-title>. <source>RNA</source>
<volume>12</volume>:<fpage>1262</fpage>&#x02013;<lpage>1270</lpage>. doi:<pub-id pub-id-type="doi">10.1261/rna.61206</pub-id>.<pub-id pub-id-type="pmid">16699167</pub-id></mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brandi</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Maffioli</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Donadio</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Quaglia</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Sette</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Mil&#x000f3;n</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Gualerzi</surname><given-names>CO</given-names></name>, <name name-style="western"><surname>Fabbretti</surname><given-names>A</given-names></name></person-group>
<year>2012</year>
<article-title>Structural and functional characterization of the bacterial translocation inhibitor GE82832</article-title>. <source>FEBS Lett</source>
<volume>586</volume>:<fpage>3373</fpage>&#x02013;<lpage>3378</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.febslet.2012.07.040</pub-id>.<pub-id pub-id-type="pmid">22841550</pub-id></mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bulkley</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Brandi</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Polikanov</surname><given-names>YS</given-names></name>, <name name-style="western"><surname>Fabbretti</surname><given-names>A</given-names></name>, <name name-style="western"><surname>O&#x02019;Connor</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Gualerzi</surname><given-names>CO</given-names></name>, <name name-style="western"><surname>Steitz</surname><given-names>TA</given-names></name></person-group>
<year>2014</year>
<article-title>The antibiotics dityromycin and GE82832 bind protein S12 and block EF-G-catalyzed translocation</article-title>. <source>Cell Rep</source>
<volume>6</volume>:<fpage>357</fpage>&#x02013;<lpage>365</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.celrep.2013.12.024</pub-id>.<pub-id pub-id-type="pmid">24412368</pub-id></mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Demirci</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Murphy</surname><given-names>FV</given-names></name>, <name name-style="western"><surname>Murphy</surname><given-names>EL</given-names></name>, <name name-style="western"><surname>Carr</surname><given-names>JF</given-names></name>, <name name-style="western"><surname>Blanchard</surname><given-names>SC</given-names></name>, <name name-style="western"><surname>Jogl</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Dahlberg</surname><given-names>AE</given-names></name>, <name name-style="western"><surname>Gregory</surname><given-names>ST</given-names></name></person-group>
<year>2013</year>
<article-title>The central role of protein S12 in organizing the structure of the decoding site of the ribosome</article-title>. <source>RNA</source>
<volume>19</volume>:<fpage>1791</fpage>&#x02013;<lpage>1801</lpage>. doi:<pub-id pub-id-type="doi">10.1261/rna.040030.113</pub-id>.<pub-id pub-id-type="pmid">24152548</pub-id></mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hopwood</surname><given-names>DA</given-names></name></person-group>
<year>2007</year>
<article-title>How do antibiotic-producing bacteria ensure their self-resistance before antibiotic biosynthesis incapacitates them?</article-title>
<source>Mol Microbiol</source>
<volume>63</volume>:<fpage>937</fpage>&#x02013;<lpage>940</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1365-2958.2006.05584.x</pub-id>.<pub-id pub-id-type="pmid">17238916</pub-id></mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Douthwaite</surname><given-names>S</given-names></name></person-group>
<year>2002</year>
<article-title>Methylation at nucleotide G745 or G748 in 23S rRNA distinguishes Gram-negative from Gram-positive bacteria</article-title>. <source>Mol Microbiol</source>
<volume>44</volume>:<fpage>195</fpage>&#x02013;<lpage>204</lpage>. doi:<pub-id pub-id-type="doi">10.1046/j.1365-2958.2002.02866.x</pub-id>.<pub-id pub-id-type="pmid">11967079</pub-id></mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moric</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Savic</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ilic-Tomic</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Vojnovic</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Bajkic</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Vasiljevic</surname><given-names>B</given-names></name></person-group>
<year>2010</year>
<article-title>rRNA methyltransferases and their role in resistance to antibiotics</article-title>. <source>J Med Biochem</source>
<volume>29</volume>:<fpage>165</fpage>&#x02013;<lpage>174</lpage>. doi:<pub-id pub-id-type="doi">10.2478/v10011-010-0030-y</pub-id>.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mousa</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Bruner</surname><given-names>SD</given-names></name></person-group>
<year>2016</year>
<article-title>Structural and mechanistic diversity of multidrug transporters</article-title>. <source>Nat Prod Rep</source>
<volume>33</volume>:<fpage>1255</fpage>&#x02013;<lpage>1267</lpage>. doi:<pub-id pub-id-type="doi">10.1039/c6np00006a</pub-id>.<pub-id pub-id-type="pmid">27472662</pub-id></mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Giedraitien&#x00117;</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Vitkauskien&#x00117;</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Naginien&#x00117;</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Pavilonis</surname><given-names>A</given-names></name></person-group>
<year>2011</year>
<article-title>Antibiotic resistance mechanisms of clinically important bacteria</article-title>. <source>Medicina (Kaunas)</source>
<volume>47</volume>:<fpage>137</fpage>&#x02013;<lpage>146</lpage>.<pub-id pub-id-type="pmid">21822035</pub-id></mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Biggins</surname><given-names>JB</given-names></name>, <name name-style="western"><surname>Onwueme</surname><given-names>KC</given-names></name>, <name name-style="western"><surname>Thorson</surname><given-names>JS</given-names></name></person-group>
<year>2003</year>
<article-title>Resistance to enediyne antitumor antibiotics by CalC self-sacrifice</article-title>. <source>Science</source>
<volume>301</volume>:<fpage>1537</fpage>&#x02013;<lpage>1541</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.1086695</pub-id>.<pub-id pub-id-type="pmid">12970566</pub-id></mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Galm</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Hager</surname><given-names>MH</given-names></name>, <name name-style="western"><surname>Van Lanen</surname><given-names>SG</given-names></name>, <name name-style="western"><surname>Ju</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Thorson</surname><given-names>JS</given-names></name>, <name name-style="western"><surname>Shen</surname><given-names>B</given-names></name></person-group>
<year>2005</year>
<article-title>Antitumor antibiotics: bleomycin, enediynes, and mitomycin</article-title>. <source>Chem Rev</source>
<volume>105</volume>:<fpage>739</fpage>&#x02013;<lpage>758</lpage>. doi:<pub-id pub-id-type="doi">10.1021/cr030117g</pub-id>.<pub-id pub-id-type="pmid">15700963</pub-id></mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reimer</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Pos</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Thines</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Grun</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Bode</surname><given-names>HB</given-names></name></person-group>
<year>2011</year>
<article-title>A natural prodrug activation mechanism in nonribosomal peptide synthesis</article-title>. <source>Nat Chem Biol</source>
<volume>7</volume>:<fpage>888</fpage>&#x02013;<lpage>890</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nchembio.688</pub-id>.<pub-id pub-id-type="pmid">21926994</pub-id></mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brotherton</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Balskus</surname><given-names>EP</given-names></name></person-group>
<year>2013</year>
<article-title>A prodrug resistance mechanism is involved in colibactin biosynthesis and cytotoxicity</article-title>. <source>J Am Chem Soc</source>
<volume>135</volume>:<fpage>3359</fpage>&#x02013;<lpage>3362</lpage>. doi:<pub-id pub-id-type="doi">10.1021/ja312154m</pub-id>.<pub-id pub-id-type="pmid">23406518</pub-id></mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Wen</surname><given-names>W-H</given-names></name>, <name name-style="western"><surname>Pu</surname><given-names>J-Y</given-names></name>, <name name-style="western"><surname>Tang</surname><given-names>M-C</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Peng</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Tang</surname><given-names>G-L</given-names></name></person-group>
<year>2018</year>
<article-title>Extracellularly oxidative activation and inactivation of matured prodrug for cryptic self-resistance in naphthyridinomycin biosynthesis</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>115</volume>:<fpage>11232</fpage>&#x02013;<lpage>11237</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.1800502115</pub-id>.<pub-id pub-id-type="pmid">30327344</pub-id></mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jiang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Hashim Ellabaan</surname><given-names>MM</given-names></name>, <name name-style="western"><surname>Charusanti</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Munck</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Blin</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Tong</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Weber</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Sommer</surname><given-names>MOA</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>SY</given-names></name></person-group>
<year>2017</year>
<article-title>Dissemination of antibiotic resistance genes from antibiotic producers to pathogens</article-title>. <source>Nat Commun</source>
<volume>8</volume>:<fpage>15784</fpage>. doi:<pub-id pub-id-type="doi">10.1038/ncomms15784</pub-id>.<pub-id pub-id-type="pmid">28589945</pub-id></mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Napolioni</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Cimarelli</surname><given-names>L</given-names></name>, <name name-style="western"><surname>La Miano</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Teana</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Capuni</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Giuliodori</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Fabbretti</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Spurio</surname><given-names>R</given-names></name></person-group>
<year>2019</year>
<article-title>Draft genome sequence of Streptomyces sp. AM-2504, identified by 16S rRNA comparative analysis as a Streptomyces kasugaensis strain</article-title>. <source>Microbiol Resour Announc</source>
<volume>8</volume>:<elocation-id>e00966-19</elocation-id>. doi:<pub-id pub-id-type="doi">10.1128/MRA.00966-19</pub-id>.<pub-id pub-id-type="pmid">31537672</pub-id></mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>D&#x02019;Costa</surname><given-names>VM</given-names></name>, <name name-style="western"><surname>McGrann</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Hughes</surname><given-names>DW</given-names></name>, <name name-style="western"><surname>Wright</surname><given-names>GD</given-names></name></person-group>
<year>2006</year>
<article-title>Sampling the antibiotic resistome</article-title>. <source>Science</source>
<volume>311</volume>:<fpage>374</fpage>&#x02013;<lpage>377</lpage>. doi:<pub-id pub-id-type="doi">10.1126/science.1120800</pub-id>.<pub-id pub-id-type="pmid">16424339</pub-id></mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Perry</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Westman</surname><given-names>EL</given-names></name>, <name name-style="western"><surname>Wright</surname><given-names>GD</given-names></name></person-group>
<year>2014</year>
<article-title>The antibiotic resistome: what&#x02019;s new?</article-title>
<source>Curr Opin Microbiol</source>
<volume>21</volume>:<fpage>45</fpage>&#x02013;<lpage>50</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.mib.2014.09.002</pub-id>.<pub-id pub-id-type="pmid">25280222</pub-id></mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peterson</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Kaur</surname><given-names>P</given-names></name></person-group>
<year>2018</year>
<article-title>Antibiotic resistance mechanisms in bacteria: relationships between resistance determinants of antibiotic producers, environmental bacteria, and clinical pathogens</article-title>. <source>Front Microbiol</source>
<volume>9</volume>:<fpage>2928</fpage>. doi:<pub-id pub-id-type="doi">10.3389/fmicb.2018.02928</pub-id>.<pub-id pub-id-type="pmid">30555448</pub-id></mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mak</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Nodwell</surname><given-names>JR</given-names></name></person-group>
<year>2014</year>
<article-title>The expression of antibiotic resistance genes in antibiotic-producing bacteria</article-title>. <source>Mol Microbiol</source>
<volume>93</volume>:<fpage>391</fpage>&#x02013;<lpage>402</lpage>. doi:<pub-id pub-id-type="doi">10.1111/mmi.12689</pub-id>.<pub-id pub-id-type="pmid">24964724</pub-id></mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cui</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>X-C</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Lemke</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Koppermann</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ducho</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Rohr</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Thorson</surname><given-names>JS</given-names></name>, <name name-style="western"><surname>Van Lanen</surname><given-names>SG</given-names></name></person-group>
<year>2018</year>
<article-title>Self-resistance during muraymycin biosynthesis: a complementary nucleotidyltransferase and phosphotransferase with identical modification sites and distinct temporal order</article-title>. <source>Antimicrob Agents Chemother</source>
<volume>62</volume>:<elocation-id>e00193-18</elocation-id>. doi:<pub-id pub-id-type="doi">10.1128/AAC.00193-18</pub-id>.<pub-id pub-id-type="pmid">29735559</pub-id></mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Panter</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Krug</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Baumann</surname><given-names>S</given-names></name>, <name name-style="western"><surname>M&#x000fc;ller</surname><given-names>R</given-names></name></person-group>
<year>2018</year>
<article-title>Self-resistance guided genome mining uncovers new topoisomerase inhibitors from myxobacteria</article-title>. <source>Chem Sci</source>
<volume>9</volume>:<fpage>4898</fpage>&#x02013;<lpage>4908</lpage>. doi:<pub-id pub-id-type="doi">10.1039/c8sc01325j</pub-id>.<pub-id pub-id-type="pmid">29910943</pub-id></mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Auerbach</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Bashan</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Harms</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Schluenzen</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Zarivach</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Bartels</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Agmon</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Kessler</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Pioletti</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Franceschi</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Yonath</surname><given-names>A</given-names></name></person-group>
<year>2002</year>
<article-title>Antibiotics targeting ribosomes: crystallographic studies</article-title>. <source>Curr Drug Targets Infect Disord</source>
<volume>2</volume>:<fpage>169</fpage>&#x02013;<lpage>186</lpage>. doi:<pub-id pub-id-type="doi">10.2174/1568005023342506</pub-id>.<pub-id pub-id-type="pmid">12462147</pub-id></mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wilson</surname><given-names>D</given-names></name></person-group>
<year>2014</year>
<article-title>Ribosome-targeting antibiotics and mechanisms of bacterial resistance</article-title>. <source>Nat Rev Microbiol</source>
<volume>12</volume>:<fpage>35</fpage>&#x02013;<lpage>48</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nrmicro3155</pub-id>.<pub-id pub-id-type="pmid">24336183</pub-id></mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sierra</surname><given-names>RG</given-names></name>, <name name-style="western"><surname>Gati</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Laksmono</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Han Dao</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Gul</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Fuller</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Kern</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Chatterjee</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Ibrahim</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Brewster</surname><given-names>AS</given-names></name>, <name name-style="western"><surname>Young</surname><given-names>ID</given-names></name>, <name name-style="western"><surname>Michels-Clark</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Aquila</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Liang</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Hunter</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Koglin</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Boutet</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Junco</surname><given-names>EA</given-names></name>, <name name-style="western"><surname>Hayes</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Bogan</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Hampton</surname><given-names>CY</given-names></name>, <name name-style="western"><surname>Puglisi</surname><given-names>EV</given-names></name>, <name name-style="western"><surname>Sauter</surname><given-names>NK</given-names></name>, <name name-style="western"><surname>Stan</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Zouni</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Yano</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Yachandra</surname><given-names>VK</given-names></name>, <name name-style="western"><surname>Soltis</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Puglisi</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>DeMirci</surname><given-names>H</given-names></name></person-group>
<year>2016</year>
<article-title>Concentric-flow electrokinetic injector enables serial crystallography of ribosome and photosystem II</article-title>. <source>Nat Methods</source>
<volume>13</volume>:<fpage>59</fpage>&#x02013;<lpage>62</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nmeth.3667</pub-id>.<pub-id pub-id-type="pmid">26619013</pub-id></mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Razi</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Britton</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Ortega</surname><given-names>J</given-names></name></person-group>
<year>2017</year>
<article-title>The impact of recent improvements in cryo-electron microscopy technology on the understanding of bacterial ribosome assembly</article-title>. <source>Nucleic Acids Res</source>
<volume>45</volume>:<fpage>1027</fpage>&#x02013;<lpage>1040</lpage>. doi:<pub-id pub-id-type="doi">10.1093/nar/gkw1231</pub-id>.<pub-id pub-id-type="pmid">28180306</pub-id></mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Giuliodori</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Spurio</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Milon</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Fabbretti</surname><given-names>A</given-names></name></person-group>
<year>2018</year>
<article-title>Antibiotics targeting the 30S ribosomal subunit: a lesson from nature to find and develop new drugs</article-title>. <source>Curr Top Med Chem</source>
<volume>18</volume>:<fpage>2080</fpage>&#x02013;<lpage>2096</lpage>. doi:<pub-id pub-id-type="doi">10.2174/1568026618666181025092546</pub-id>.<pub-id pub-id-type="pmid">30360712</pub-id></mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>O&#x02019;Sullivan</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Poitevin</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Sierra</surname><given-names>RG</given-names></name>, <name name-style="western"><surname>Gati</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Han Dao</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Rao</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Aksit</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Ciftci</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Corsepius</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Greenhouse</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Hayes</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Hunter</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Liang</surname><given-names>M</given-names></name>, <name name-style="western"><surname>McGurk</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Mbgam</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Obrinsky</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Pardo-Avila</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Seaberg</surname><given-names>MH</given-names></name>, <name name-style="western"><surname>Cheng</surname><given-names>AG</given-names></name>, <name name-style="western"><surname>Ricci</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Demirci</surname><given-names>H</given-names></name></person-group>
<year>2018</year>
<article-title>Aminoglycoside ribosome interactions reveal novel conformational states at ambient temperature</article-title>. <source>Nucleic Acids Res</source>
<volume>46</volume>:<fpage>9793</fpage>&#x02013;<lpage>9804</lpage>. doi:<pub-id pub-id-type="doi">10.1093/nar/gky693</pub-id>.<pub-id pub-id-type="pmid">30113694</pub-id></mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lin</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Steitz</surname><given-names>TA</given-names></name>, <name name-style="western"><surname>Polikanov</surname><given-names>YS</given-names></name>, <name name-style="western"><surname>Gagnon</surname><given-names>MG</given-names></name></person-group>
<year>2018</year>
<article-title>Ribosome-targeting antibiotics: modes of action, mechanisms of resistance, and implications for drug design</article-title>. <source>Annu Rev Biochem</source>
<volume>87</volume>:<fpage>451</fpage>&#x02013;<lpage>478</lpage>. doi:<pub-id pub-id-type="doi">10.1146/annurev-biochem-062917-011942</pub-id>.<pub-id pub-id-type="pmid">29570352</pub-id></mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Belousoff</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Venugopal</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Wright</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Seoner</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Stuart</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Stubenrauch</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Bamert</surname><given-names>RS</given-names></name>, <name name-style="western"><surname>Lupton</surname><given-names>DW</given-names></name>, <name name-style="western"><surname>Lithgow</surname><given-names>T</given-names></name></person-group>
<year>2019</year>
<article-title>cryoEM-guided development of antibiotics for drug-resistant bacteria</article-title>. <source>ChemMedChem</source>
<volume>14</volume>:<fpage>527</fpage>&#x02013;<lpage>531</lpage>. doi:<pub-id pub-id-type="doi">10.1002/cmdc.201900042</pub-id>.<pub-id pub-id-type="pmid">30667174</pub-id></mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Petrelli</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Garofalo</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Lammi</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Spurio</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Pon</surname><given-names>CL</given-names></name>, <name name-style="western"><surname>Gualerzi</surname><given-names>CO</given-names></name>, <name name-style="western"><surname>La Teana</surname><given-names>A</given-names></name></person-group>
<year>2003</year>
<article-title>Mapping the active sites of bacterial translation initiation factor IF3</article-title>. <source>J Mol Biol</source>
<volume>331</volume>:<fpage>541</fpage>&#x02013;<lpage>556</lpage>. doi:<pub-id pub-id-type="doi">10.1016/s0022-2836(03)00731-9</pub-id>.<pub-id pub-id-type="pmid">12899827</pub-id></mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Armstrong</surname><given-names>CT</given-names></name>, <name name-style="western"><surname>Mason</surname><given-names>PE</given-names></name>, <name name-style="western"><surname>Anderson</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Dempsey</surname><given-names>CE</given-names></name></person-group>
<year>2016</year>
<article-title>Arginine side chain interactions and the role of arginine as a gating charge carrier in voltage sensitive ion channels</article-title>. <source>Sci Rep</source>
<volume>6</volume>:<fpage>21759</fpage>. doi:<pub-id pub-id-type="doi">10.1038/srep21759</pub-id>.<pub-id pub-id-type="pmid">26899474</pub-id></mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Funatsu</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Wittmann</surname><given-names>HG</given-names></name></person-group>
<year>1972</year>
<article-title>Ribosomal proteins. XXXIII. Location of amino-acid replacements in protein S12 isolated from Escherichia coli mutants resistant to streptomycin</article-title>. <source>J Mol Biol</source>
<volume>68</volume>:<fpage>547</fpage>&#x02013;<lpage>550</lpage>. doi:<pub-id pub-id-type="doi">10.1016/0022-2836(72)90108-8</pub-id>.<pub-id pub-id-type="pmid">4560854</pub-id></mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shima</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Hesketh</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Okamoto</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kawamoto</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ochi</surname><given-names>K</given-names></name></person-group>
<year>1996</year>
<article-title>Induction of actinorhodin production by <italic>rpsL</italic> (encoding ribosomal protein S12) mutations that confer streptomycin resistance in <italic>Streptomyces lividans</italic> and <italic>Streptomyces coelicolor</italic> (A3)</article-title>. <source>J Bacteriol</source>
<volume>178</volume>:<fpage>7276</fpage>&#x02013;<lpage>7284</lpage>. doi:<pub-id pub-id-type="doi">10.1128/jb.178.24.7276-7284.1996</pub-id>.<pub-id pub-id-type="pmid">8955413</pub-id></mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hosaka</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Ohnishi-Kameyama</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Muramatsu</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Murakami</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Tsurumi</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Kodani</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Yoshida</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Fujie</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Ochi</surname><given-names>K</given-names></name></person-group>
<year>2009</year>
<article-title>Antibacterial discovery in actinomycetes strains with mutations in RNA polymerase or ribosomal protein S12</article-title>. <source>Nat Biotechnol</source>
<volume>27</volume>:<fpage>462</fpage>&#x02013;<lpage>464</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nbt.1538</pub-id>.<pub-id pub-id-type="pmid">19396160</pub-id></mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aarestrup</surname><given-names>FM</given-names></name>, <name name-style="western"><surname>Jensen</surname><given-names>LB</given-names></name></person-group>
<year>2000</year>
<article-title>Presence of variations in ribosomal protein L16 corresponding to susceptibility of enterococci to oligosaccharides (avilamycin and evernimicin)</article-title>. <source>Antimicrob Agents Chemother</source>
<volume>44</volume>:<fpage>3425</fpage>&#x02013;<lpage>3427</lpage>. doi:<pub-id pub-id-type="doi">10.1128/aac.44.12.3425-3427.2000</pub-id>.<pub-id pub-id-type="pmid">11083650</pub-id></mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Adrian</surname><given-names>PV</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Black</surname><given-names>TA</given-names></name>, <name name-style="western"><surname>Shaw</surname><given-names>KJ</given-names></name>, <name name-style="western"><surname>Hare</surname><given-names>RS</given-names></name>, <name name-style="western"><surname>Klugman</surname><given-names>KP</given-names></name></person-group>
<year>2000</year>
<article-title>Mutations in ribosomal protein L16 conferring reduced susceptibility to evernimicin (SCH27899): implications for mechanism of action</article-title>. <source>Antimicrob Agents Chemother</source>
<volume>44</volume>:<fpage>732</fpage>&#x02013;<lpage>738</lpage>. doi:<pub-id pub-id-type="doi">10.1128/aac.44.3.732-738.2000</pub-id>.<pub-id pub-id-type="pmid">10681347</pub-id></mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kehrenberg</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Schwarz</surname><given-names>S</given-names></name></person-group>
<year>2007</year>
<article-title>Mutations in 16S rRNA and ribosomal protein S5 associated with high-level spectinomycin resistance in <italic>Pasteurella multocida</italic></article-title>. <source>Antimicrob Agents Chemother</source>
<volume>51</volume>:<fpage>2244</fpage>&#x02013;<lpage>2246</lpage>. doi:<pub-id pub-id-type="doi">10.1128/AAC.00229-07</pub-id>.<pub-id pub-id-type="pmid">17371823</pub-id></mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Milon</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Konevega</surname><given-names>AL</given-names></name>, <name name-style="western"><surname>Peske</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Fabbretti</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Gualerzi</surname><given-names>CO</given-names></name>, <name name-style="western"><surname>Rodnina</surname><given-names>MV</given-names></name></person-group>
<year>2007</year>
<article-title>Transient kinetics, fluorescence, and FRET in studies of initiation of translation in bacteria</article-title>. <source>Methods Enzymol</source>
<volume>430</volume>:<fpage>1</fpage>&#x02013;<lpage>30</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0076-6879(07)30001-3</pub-id>.<pub-id pub-id-type="pmid">17913632</pub-id></mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brandi</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Fabbretti</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Milon</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Carotti</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Pon</surname><given-names>CL</given-names></name>, <name name-style="western"><surname>Gualerzi</surname><given-names>CO</given-names></name></person-group>
<year>2007</year>
<article-title>Methods for identifying compounds that specifically target translation</article-title>. <source>Methods Enzymol</source>
<volume>431</volume>:<fpage>229</fpage>&#x02013;<lpage>267</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0076-6879(07)31012-4</pub-id>.<pub-id pub-id-type="pmid">17923238</pub-id></mixed-citation></ref></ref-list></back></article>